Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- Continuous Lidocaine Infusion for Management of Perioperative Burn Pain: Complete Statistical AnalysisIndependent statistical analysis of Continuous Lidocaine Infusion for Management of Perioperative Burn Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02059902).
- Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.: Complete Statistical AnalysisIndependent statistical analysis of Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CONTRAIL IIndependent statistical analysis of Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension: primary…
- contRAst 2Complete statistical analysis of the phase 3 contRAst 2 trial of GSK3196165 (otilimab) versus placebo and tofacitinib in moderately to severely active rheumatoid arthritis.
- Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Contrast-enhanced Ultrasound Evaluation of Chemoembolization: Complete Statistical AnalysisIndependent statistical analysis of Contrast-enhanced Ultrasound Evaluation of Chemoembolization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02764801).
- CONTROLIndependent statistical analysis of Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00184548).
- Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): Complete Statistical AnalysisIndependent statistical analysis of Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia: Complete Statistical AnalysisIndependent statistical analysis of Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Convalescent Plasma vs. Standard Plasma for COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Convalescent Plasma vs. Standard Plasma for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04344535).
- Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03762473).
- Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- COOLIndependent statistical analysis of A Proof of Concept Study to Investigate the Use and Relevance of a Digital Platform for Infant Crying and Fussing: primary endpoint results, effect estimate with confidence interval,…
- Cooling Vest May Reduce Heat Stress During Surgery: Complete Statistical AnalysisIndependent statistical analysis of Cooling Vest May Reduce Heat Stress During Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04511208).
- Coordinated Emergency Department Transitions: Complete Statistical AnalysisIndependent statistical analysis of Coordinated Emergency Department Transitions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06933849).
- Coordinated Oral Health Promotion (CO-OP) Chicago: Complete Statistical AnalysisIndependent statistical analysis of Coordinated Oral Health Promotion (CO-OP) Chicago: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03397589).
- Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COPDIndependent statistical analysis of A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COPDIndependent statistical analysis of COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- COPEIndependent statistical analysis of A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- COPE-HCVIndependent statistical analysis of Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: Complete Statistical AnalysisIndependent statistical analysis of CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00889265).
- Copper Histidine Therapy for Menkes Diseases: Complete Statistical AnalysisIndependent statistical analysis of Copper Histidine Therapy for Menkes Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00001262).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662060).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662073).
- CoQ10Independent statistical analysis of Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Corneal Nerves Function and Structure: Complete Statistical AnalysisIndependent statistical analysis of Corneal Nerves Function and Structure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04222660).
- Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear: Complete Statistical AnalysisIndependent statistical analysis of Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): Complete Statistical AnalysisIndependent statistical analysis of Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00353795).
- Coronary MDCTA With Iopamidol Injection 370: Complete Statistical AnalysisIndependent statistical analysis of Coronary MDCTA With Iopamidol Injection 370: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00558792).
- CorPath® GRX Neuro Study: Complete Statistical AnalysisIndependent statistical analysis of CorPath® GRX Neuro Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04236856).
- Cortical Contributions to Motor Sequence Learning: Complete Statistical AnalysisIndependent statistical analysis of Cortical Contributions to Motor Sequence Learning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04138953).
- Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: Complete Statistical AnalysisIndependent statistical analysis of Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01227980).
- Cortisol Response to Moderate and Deep Sedation in Children: Complete Statistical AnalysisIndependent statistical analysis of Cortisol Response to Moderate and Deep Sedation in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265966).
- COSMOSIndependent statistical analysis of A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COSMOSIndependent statistical analysis of A Study in Participants With Non-cirrhotic NASH With Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05638737).
- COSMOS-MindIndependent statistical analysis of COcoa Supplement and Multivitamin Outcomes Study for the Mind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03035201).
- Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain: Complete Statistical AnalysisIndependent statistical analysis of Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- COU-AA-301Independent statistical analysis of COU-AA-301, a randomized phase 3 trial of abiraterone acetate in castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy, covering overall survival, progression, PSA response, trial design, and statistical…
- COUGH-1Independent statistical analysis of Safety and Tolerability of COVID-19 Vaccine (ABNCoV2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04839146).
- COVACTAIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- COVENANTIndependent statistical analysis of HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CoverEdge Algorithm Programming Study: Complete Statistical AnalysisIndependent statistical analysis of CoverEdge Algorithm Programming Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02492880).
- COVID SAFE 2Independent statistical analysis of COVID-19 Screening Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05216627).
- COVID-19Independent statistical analysis of Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05973006).
- COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05584189).
- COVID-19 PrEP HCW HCQ Study: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 PrEP HCW HCQ Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04354870).
- COVID-19 Project ECHO in Nursing Homes: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Project ECHO in Nursing Homes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04499391).